Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 059868/0452 | |
| Pages: | 7 |
| | Recorded: | 05/09/2022 | | |
| Attorney Dkt #: | FNJ-026 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17691645
|
Filing Dt:
|
03/10/2022
|
|
Publication #:
|
|
Pub Dt:
|
09/15/2022
| | | | |
|
Title:
|
DOSAGE AND ADMINISTRATION OF ANTI-ERBB3 (HER3) MONOCLONAL ANTIBODIES TO TREAT TUMORS ASSOCIATED WITH NEUREGULIN 1 (NRG1) GENE FUSIONS
|
|
|
Assignee
|
|
|
|
|
| 888 7TH AVE. |
| 12TH FLOOR |
| NEW YORK, NEW YORK 10106 |
|
|
Correspondence name and address
|
| |
NELSON MULLINS RILEY & SCARBOROUGH LLP
|
| |
ONE FINANCIAL CENTER
|
| |
SUITE 3500
|
| |
BOSTON, MA 02111
|
Search Results as of:
05/29/2024 03:47 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
